CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue		$ 25,663	$ 13,854	$ 5,511
Cost of revenue		17,447	9,401	3,606
Gross profit		8,216	4,453	1,905
Operating expenses:
Research and development, net		4,625	4,148	4,031
Sales and marketing		17,949	13,922	9,842
General and administrative		5,195	9,995	7,134
Impairment charges		9,794	0	0
Total operating expenses		37,563	28,065	21,007
Operating loss		(29,347)	(23,612)	(19,102)
Financial income, net		448	1,467		[1]
Loss before income taxes		(28,899)	(22,145)	(19,102)
Taxes on income (benefit)		43	(12)	467
Net loss		$ (28,942)	$ (22,133)	$ (19,569)
Net loss per ordinary share, basic		$ (3.33)	$ (2.59)	$ (2.2)
Net loss per ordinary share, diluted		$ (3.33)	$ (2.59)	$ (2.2)
Weighted average number of shares used in computing net loss per ordinary share, basic	[2]	8,691,271	8,531,294	8,911,256
Weighted average number of shares used in computing net loss per ordinary share, diluted	[2]	8,691,271	8,531,294	8,911,256

[1] Represents an amount lower than $1.

[2] Reflects one-for-seven reverse share split that became effective on March 15, 2024. See Note 9a to the consolidated financial statements.